INDEGENE
Back to Income Statement
|
INDEGENE Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹407 Cr | ₹337 Cr | ₹266 Cr | ₹165 Cr | ₹149 Cr |
What is the latest Consolidated Net Profit of INDEGENE ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹407 Cr |
Mar2024 | ₹337 Cr |
Mar2023 | ₹266 Cr |
Mar2022 | ₹165 Cr |
Mar2021 | ₹149 Cr |
How is Consolidated Net Profit of INDEGENE Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹407 Cr | 20.79 | |
Mar2024 | ₹337 Cr | 26.53 | |
Mar2023 | ₹266 Cr | 61.51 | |
Mar2022 | ₹165 Cr | 10.28 | |
Mar2021 | ₹149 Cr | - |
Compare Consolidated Net Profit of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹13,474.4 Cr | -2.7% | -2.7% | -1.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,872.0 Cr | -2.1% | 1.7% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,609.0 Cr | -1.5% | 1.5% | 46.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,277.0 Cr | 2.5% | 11.2% | 15.3% | Stock Analytics | |
CIPLA | ₹119,184.0 Cr | -1% | -1.7% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,116.0 Cr | -0.1% | -5% | -5.6% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | -2.7% |
-2.7% |
-1.2% |
SENSEX | -0.1% |
1% |
1.8% |
You may also like the below Video Courses